Amelioration of pulmonary emphysema by in vivo gene transfection with hepatocyte growth factor in rats

Circulation

Volumn 111, Issue 11, 2005, Pages 1407-1414

  Shigemura, Norihisa ^a   Sawa, Yoshiki ^a   Mizuno, Shinya ^a   Ono, Masamichi ^a   Ohta, Mitsunori ^a   Nakamura, Toshikazu ^a   Kaneda, Yasufumi ^a   Matsuda, Hikaru ^a  

^a OSAKA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Angiogenesis; Gene therapy; Growth substances; Hypoxia; Lung

Indexed keywords

MESSENGER RNA; SCATTER FACTOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CELL WALL; CONTROLLED STUDY; CORRELATION ANALYSIS; DNA TRANSFECTION; EXERCISE TOLERANCE; GAS EXCHANGE; GENE EXPRESSION; GENETIC CODE; GENETIC TRANSFECTION; HISTOLOGY; JAPAN; LUNG EMPHYSEMA; LUNG FUNCTION; NONHUMAN; PRIORITY JOURNAL; RAT;

ANIMALS; APOPTOSIS; CELL DIVISION; DISEASE MODELS, ANIMAL; DNA, COMPLEMENTARY; GENE THERAPY; GENES, REPORTER; GENETIC VECTORS; HEPATOCYTE GROWTH FACTOR; HUMANS; LASER-DOPPLER FLOWMETRY; MALE; NEOVASCULARIZATION, PHYSIOLOGIC; PANCREATIC ELASTASE; PHENOTYPE; PROTO-ONCOGENE PROTEINS C-MET; PULMONARY CIRCULATION; PULMONARY EMPHYSEMA; RANDOM ALLOCATION; RATS; RATS, SPRAGUE-DAWLEY; RECOMBINANT FUSION PROTEINS; RESPIRATORY FUNCTION TESTS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; SENDAI VIRUS; TRANSDUCTION, GENETIC;

EID: 15444375818     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.CIR.0000158433.89103.85     Document Type: Article

References (41)

1. American Thoracic Society. Standards for the diagnosis and care of patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 1995;152:S77-S121.
2. Cooper JD, Patterson GA, Sundaresan RS. Results of 150 consecutive bilateral lung volume reduction procedures in patients with severe emphysema. J Thorac Cardiovasc Surg. 1996;112:1319-1330.
3. National Emphysema Treatment Trial Group. A randomized trial comparing lung-volume-reduction surgery with medical therapy for severe emphysema. N Engl J Med. 2003;348:2059-2073.
4. Snider GL. Chronic obstructive pulmonary disease: a definition and implications of structural determinations of airflow obstruction for epidemiology. Am Rev Respir Dis. 1989;140:S3-S8.
5. Gardi C, Martorana PA, Santi MM. A biochemical and morphological investigation of the early development of genetic emphysema in tight-skin mice. Exp Mol Pathol. 1989;50:398-410.
6. Aoshiba K, Yokohori N, Nagai A. Alveolar wall apoptosis causes lung destruction and emphysematous changes. Am J Respir Cell Mol Biol. 2003;28:555-562.
7. Nakamura T, Nawa K, Ichihara A. Partial purification and characterization of hepatocyte growth factor from serum of hepatomized rats. Biochem Biophys Res Commun. 1984;122:1450-1459.
8. Nakamura T, Nishizawa M, Hagiya M, Seki T, Shimonishi M, Sugimura A, Tashiro K, Shimizu S. Molecular cloning and expression of human hepatocyte growth factor. Nature. 1989;342:440-443.
9. Matsumoto K, Nakamura T. Hepatocyte growth factor: renotrophic role and potential therapeutics for renal diseases. Kidney Int. 2001;59:2023-2038.
10. Mason RJ. Hepatocyte growth factor: the key to alveolar septation? Am J Respir Cell Mol Biol. 2002;26:517-520.
11. Ohmichi H, Koshimizu U, Matsumoto K, Nakamura T. Hepatocyte growth factor (HGF) acts as a mesenchyme-derived morphogenic factor during lung development. Development. 1998;125:1315-1324.
12. Ohmichi H, Matsumoto K, Nakamura T. In vivo mitogenic action of HGF on lung epithelial cells: pulmotrophic role in lung regeneration. Am J Physiol. 1996;270:L1031-L1039.
13. Yamada T, Hisanaga M, Nakajima Y, Mizuno S, Matsumoto K, Nakamura T, Nakano H. Enhanced expression of hepatocyte growth factor by pulmonary ischemia-reperfusion injury in the rat. Am J Respir Crit Care Med. 2000;162:707-715.
14. Sakamaki Y, Matsumoto K, Mizuno S, Miyoshi S, Matsuda H, Nakamura T. Hepatocyte growth factor stimulates proliferation of respiratory epithelial cells during postpneumonectomy compensatory lung growth in mice. Am J Respir Cell Mol Biol. 2002;26:525-533.
15. Mason RJ, McCormick-Shannon K, Rubin JS, Nakamura T, Leslie CC. Hepatocyte growth factor is a mitogen for alveolar type II cells in rat lavage fluid. Am J Physiol. 1996;271:L46-L53.
16. Hayashi S, Morishita R, Nakamura S, Yamamoto K, Moriguchi A, Nagano T, Taiji M, Noguchi H, Matsumoto K, Nakamura T, Higaki J, Ogihara T. Potential role of hepatocyte growth factor, a novel angiogenic growth factor, in peripheral arterial disease: downregulation of HGF in response to hypoxia in vascular cells. Circulation. 1999;100:301-308.
17. Miyagawa S, Sawa Y, Taketani S, Kawaguchi N, Nakamura T, Matsuura S, Matsuda H. Myocardial regeneration therapy for heart failure: hepatocyte growth factor enhances the effect of cellular cardiomyoplasty. Circulation. 2002;105:2556-2561.
18. Yoshida S, Yamaguchi Y, Itami S, Yoshikawa K, Tabata Y, Matsumoto K, Nakamura T. Neutralization of hepatocyte growth factor leads to retarded cutaneous wound healing associated with decreased neovascularization and granulation tissue formation. J Invest Dermatol. 2003;120:335-343.
19. Nakanishi K, Uenoyama M, Tomita N, Morishita R, Kaneda Y, Ogihara T, Matsumoto K, Nakamura T, Maruta A, Matsuyama S, Kawai T, Aurues T, Hayashi T, Ikeda T. Gene transfer of human hepatocyte growth factor into rat skin wounds mediated by liposomes coated with the sendai virus. Am J Pathol. 2002;161:1761-1772.
20. Ono M, Sawa Y, Matsumoto K, Nakamura T, Kaneda Y, Matsuda H. In vivo gene transfection with hepatocyte growth factor via the pulmonary artery induces angiogenesis in the rat lung. Circulation. 2002;106:I261-I269.
21. Kuhn C, Tavassoli F. The scanning electron microscopy of elastase-induced emphysema: a comparison with emphysema in man. Lab Invest. 1976;34:2-9.
22. Cooney TT, Thurlbeck WM. The radical alveolar count method of Emery and Mithal: a reappraisal 1-postnatal lung growth. Thorax. 1982;37:572-579.
23. Yamada A, Matsumoto K, Iwanari H. Rapid and sensitive enzyme-linked immunosorbent assay for measurement of HGF in rat and human tissues. Biomed Res. 1995;16:105-114.
24. Kaneda Y, Iwaki K, Uchida T. Increased expression of DNA co-introduced with nuclear protein in adult rat liver. Science. 1989;243:375-378.
25. Kaneda Y, Nakajima T, Nishikawa T, Yamamoto S, Ikegami H, Suzaki N, Nakamura H, Morishita R, Kotani H. Hemagglutinating virus of Japan (HVJ) envelope vector as a versatile gene delivery system. Mol Ther. 2002;6:219-226.
26. Ueki T, Kaneda Y, Tsutsui H, Nakanishi K, Sawa Y, Morishita R, Matsumoto K, Nakamura T, Takahashi H, Okamoto E, Fujimoto J. Hepatocyte growth factor gene therapy of liver cirrhosis in rats. Nat Med. 1999;5:226-230.
27. Yoon HE, Mizuta T, Minami M, Fujii Y, Matsumura A, Nakahara K, Matsuda H. Exercise performance of rats after isogenic left or right lung transplantation followed by contralateral pulmonary artery ligation. J Heart Lung Transplant. 1996;15:605-611.
28. Cassivi SD, Meyers BF, Battafarano RJ, Guthrie TJ, Trulock EP, Lynch AP, Cooper JD, Patterson GA. Thirteen-year experience in lung transplantation for emphysema. Ann Thorac Surg. 2002;74:1663-1670.
29. Yanagita K, Nagaike M, Ishibashi H, Niho Y, Matsumoto K, Nakamura T. Lung may have endocrine function producing hepatocyte growth factor in response to injury of distal organs. Biochem Biophys Res Commun. 1992;182:802-809.
30. Corpechot C, Barbu V, Wendum D, Chignard N, Housset C, Poupon R, Rosmorduc O. Hepatocyte growth factor and c-Met inhibition by hepatic cell hypoxia: a potential mechanism for liver regeneration failure. Am J Pathol. 2002;160:613-620.
31. Hayashi S, Morishita R, Higaki J, Aoki M, Moriguchi A, Kida I, Yoshiki S, Matsumoto K, Nakamura T, Kaneda Y. Autocrine-paracrine effects of overexpression of hepatocyte growth factor gene on growth of endothelial cells. Biochem Biophys Res Commun. 1996;220:539-545.
32. Shimamura M, Sato N, Oshima K, Aoki M, Kurinami H, Waguri S, Uchiyama Y, Ogihara T, Kaneda Y, Morishita R. Novel therapeutic strategy to treat brain ischemia. Circulation. 2004;109:424-431.
33. Matsumoto K, Tajima H, Okazaki H, Nakamura T. Negative regulation of hepatocyte growth factor gene expression in human lung fibroblasts and leukemic cells by transforming growth factor-beta 1 and glucocorticoids. J Biol Chem. 1992;267:24917-24920.
34. Nakano N, Morishita R, Moriguchi A, Nakamura Y, Hayashi S, Aoki M, Kida I, Matsumoto K, Nakamura T, Higaki J, Ogihara T. Negative regulation of local hepatocyte growth factor expression by angiotensin II and transforming growth factor-beta in blood vessels. Hypertension. 1998;32:444-451.
35. Mizuno S, Nakamura T. Suppressions of chronic glomerular injuries and TGF-beta1 production by HGF in attenuation of murine diabetic nephropathy. Am J Physiol Renal Physiol. 2004;286:F134-F143.
36. Tsubari M, Taipale J, Tiihonen E, Keski-Oja J, Laiho M. Hepatocyte growth factor releases mink epithelial cells from transforming growth factor beta 1-induced growth arrest by restoring Cdk6 expression and cyclin E-associated Cdk2 activity. Mol Cell Biol. 1999;19:3654-3663.
37. Liebow AA. Pulmonary emphysema with special reference to vascular changes. Am Rev Respir Dis. 1959;80:67-93.
38. Karmpaliotis D, Kosmidou I, Ingenito EP, Hong K, Malhotra A, Sunday M, Haley KJ. Angiogenic growth factors in the pathophysiology of a murine model of acute lung injury. Am J Physiol Lung Cell Mol Physiol. 2002;283:L585-L595.
39. Kasahara Y, Tuder RB, Cool CD. Endothelial cell death and decreased expression of vascular endothelial growth factor and vascular endothelial growth factor receptor 2 in emphysema. Am J Respir Crit Care Med. 2001;163:737-744.
40. Kaneda Y. Improvements in gene therapy technologies. Mol Urol. 2001;5:85-89.
41. Massaro GD, Massaro D. Retinoic acid treatment abrogates elastase-induced pulmonary emphysema in rats. Nat Med. 1997;3:675-677.